Synthetic scaffolds for 3D cell cultures and organoids: applications in regenerative medicine
The DOI matches its Crossref record; 131 of the 132 references it cites were found in a registry or an index.
Abstract
Three-dimensional (3D) cell cultures offer an unparalleled platform to recreate spatial arrangements of cells in vitro. 3D cell culture systems have gained increasing interest due to their evident advantages in providing more physiologically relevant information and more predictive data compared to their two-dimensional (2D) counterpart. Design and well-established fabrication of organoids (a particular type of 3D cell culture system) are nowadays considered a pivotal achievement for their ability to replicate in vitro cytoarchitecture and the functionalities of an organ. In this condition, pluripotent stem cells self-organize into 3D structures mimicking the in vivo microenvironments, architectures and multi-lineage differentiation. Scaffolds are key supporting elements in these 3D constructs, and Matrigel is the most commonly used matrix despite its relevant translation limitations including animal-derived sources, non-defined composition, batch-to-batch variability and poorly tailorable properties. Alternatively, 3D synthetic scaffolds, including self-assembling peptides, show promising biocompatibility and biomimetic properties, and can be tailored on specific target tissue/cells. In this review, we discuss the recent advances on 3D cell culture systems and organoids, promising tools for tissue engineering and regenerative medicine applications. For this purpose, we will describe the current state-of-the-art on 3D cell culture systems and organoids based on currently available synthetic-based biomaterials (including tailored self-assembling peptides) either tested in in vivo animal models or developed in vitro with potential application in the field of tissue engineering, with the aim to inspire researchers to take on such promising platforms for clinical applications in the near future.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“On the other hand, drug treatments may alleviate symptoms and slow disease progression but cannot fundamentally restore liver function [20–23].”
From Constructing biomimetic microenvironments for liver regeneration (2025) · doi:10.1186/s12951-025-03729-9 · cites this paper as [22]
Citations
Cites
Matrix elasticity directs stem cell lineage specification
Engler, A. J., Sen, S., Sweeney, H. L., & Discher, D. E. (2006) · Cell · doi:10.1016/j.cell.2006.06.044 · Cited by 13,915
Cerebral organoids model human brain development and microcephaly
Lancaster, M. A., Renner, M., Martin, C.-A., Wenzel, D., Bicknell, L. S., Hurles, M. E., Homfray, T., Penninger, J. M., Jackson, A. P., & Knoblich, J. A. (2013) · Nature · doi:10.1038/nature12517 · Cited by 5,372 · cited 2×
“production of organoids in the fields of: developmental and stem cell biology [58], disease modeling [59] and drug discovery [60].”
BackgroundSelf-Assembly and Mineralization of Peptide-Amphiphile Nanofibers
Hartgerink, J. D., Beniash, E., & Stupp, S. I. (2001) · Science · doi:10.1126/science.1063187 · Cited by 3,601
Hydrogels as extracellular matrix mimics for 3D cell culture
Tibbitt, M. W., & Anseth, K. S. (2009) · Biotechnology and Bioengineering · doi:10.1002/bit.22361 · Cited by 2,727 · cited 1×
“Also, hydrogel matrices can better mimic viscoelastic and topographical properties of ECM and, by means of moieties decorating their nanostructures, may also favor cell–cell or cell-matrix interactions [51].”
BackgroundHuman organoids: model systems for human biology and medicine
Kim, J., Koo, B.-K., & Knoblich, J. A. (2020) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0259-3 · Cited by 2,187 · cited 2×
“Indeed, an organoid is a subtype of 3D cell culture system that mimics its corresponding tissue in terms of morphology, structure and, in particular, functionality (Figure 1) [11].”
BackgroundA living biobank of breast cancer organoids captures disease heterogeneity
Sachs, N., de Ligt, J., Kopper, O., Gogola, E., Bounova, G., Weeber, F., Balgobind, A. V., Wind, K., Gracanin, A., Begthel, H., et al. (2018) · Cell · doi:10.1016/j.cell.2017.11.010 · Cited by 1,973
BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain
Coull, J. A. M., Beggs, S., Boudreau, D., Boivin, D., Tsuda, M., Inoue, K., Gravel, C., Salter, M. W., & De Koninck, Y. (2005) · Nature · doi:10.1038/nature04223 · Cited by 1,965
Modeling physiological events in 2D vs. 3D cell culture
Duval, K., Grover, H., Han, L.-H., Mou, Y., Pegoraro, A. F., Fredberg, J., & Chen, Z. (2017) · Physiology · doi:10.1152/physiol.00036.2016 · Cited by 1,849
Generation of cerebral organoids from human pluripotent stem cells
Lancaster, M. A., & Knoblich, J. A. (2014) · Nature Protocols · doi:10.1038/nprot.2014.158 · Cited by 1,823 · cited 1×
“Also, 3D culture systems and organoids can be maintained in culture for long timeframes (up to 1year) [20] and they can be expanded after dissociation and subsequent re-plating, enabling the generation of clonal cultures [21,22].”
BackgroundIs it time to start transitioning from 2D to 3D cell culture?
Jensen, C., & Teng, Y. (2020) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2020.00033 · Cited by 1,640
Research works printed but not linked: 2
- Varaa N, 2018, Iran J Basic Med Sci, 21, 928
- Zhang S., 2017, Royal Soc, 7, 20170028
Cited by
Advancements in tissue engineering for cardiovascular health: a biomedical engineering perspective
Razavi, Z.-S., Soltani, M., Mahmoudvand, G., Farokhi, S., Karimi-Rouzbahani, A., Farasati-Far, B., Tahmasebi-Ghorabi, S., Pazoki-Toroudi, H., & Afkhami, H. (2024) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2024.1385124 · Cited by 64
“Among the several techniques employed for scaffold construction, the electrical approach has been identi fi ed as the most effective (Marchini and Gelain, 2022).”
MethodBhattacharya, A., Alam, K., Roy, N. S., Kaur, K., Kaity, S., Ravichandiran, V., & Roy, S. (2023) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-023-02926-4 · Cited by 66
“It is important to ensure that the scaffold has the same capabilities as those of natural tissues [9].”
BackgroundExtracellular vesicles: From large-scale production and engineering to clinical applications
Wang, Y., Xiong, J., Ouyang, K., Ling, M., Luo, J., Sun, J., Xi, Q., Chen, T., & Zhang, Y. (2025) · Journal of Tissue Engineering · doi:10.1177/20417314251319474 · Cited by 61
“193 Research has demonstrated that the yield of MSCs EVs from 3D cultures is over 20 times higher than that from 2D cultures.”
Functional bioengineered models of the central nervous system
Rouleau, N., Murugan, N. J., & Kaplan, D. L. (2023) · Nature Reviews Bioengineering · doi:10.1038/s44222-023-00027-7 · Cited by 55
Chen, W., Wu, P., Jin, C., Chen, Y. E., Li, C., & Qian, H. (2024) · Journal of Nanobiotechnology · doi:10.1186/s12951-024-02455-y · Cited by 44
“On the other hand, synthetic scaffolds contain scaffolds synthesized from materials such as polyethylene glycol (PEG) [109, 110], polyvinyl alcohol (PVA) [111], poly lactic-co-glycolic acid (PLGA) [112, 113], polylactic acid (PLA) [114], polycaprolactone (PCL) [115, 116] and others [70].”
Background
Metadata
- Authors
- Marchini, A., & Gelain, F.
- Affiliations
- Casa Sollievo della Sofferenza (IT)
- Corresponding author
- Gelain, Fabrizio
- Venue
- Critical Reviews in Biotechnology
- Publisher
- Informa UK Limited
- Published
- 2021-06-30
- Volume
- 42
- Issue
- 3
- Pages
- 468-486
- ISSN
- 0738-8551 (ISSN-L)
- 1549-7801
- OpenAlex
- W3175306998
- Cited by
- 91
- References
- 132
- Citations by year
- 2026: 18 · 2025: 31 · 2024: 20 · 2023: 16 · 2022: 5 · 2021: 1
- FWCI
- 0.89
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Critical Reviews in Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute for Insurance against Accidents (BRIC2019ID25)
- Italian Ministry of Health (Ricerca Corrente 2018-2020)
- Topics
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Health Sciences › Medicine › Surgery › Tissue Engineering and Regenerative Medicine
- Physical Sciences › Materials Science › Biomaterials › Supramolecular Self-Assembly in Materials
- Keywords
- synthetic scaffolds, 3D cell culture, organoids, self-assembling peptides, pluripotent stem cells, tissue engineering, regenerative medicine, biomaterials, pluripotent stem cell differentiation, in vivo animal models
- MeSH terms
- Cell Culture Techniques, Three Dimensional, Animals, Organoids, Peptides, Tissue Engineering, Regenerative Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Synthetic scaffolds for 3D cell cultures and organoids: applications in regenerative medicine. https://app.cochat.ai/papers/10.1080/07388551.2021.1932716
- The paper
- Marchini, A., & Gelain, F. (2022). Synthetic scaffolds for 3D cell cultures and organoids: applications in regenerative medicine. Critical Reviews in Biotechnology. https://doi.org/10.1080/07388551.2021.1932716
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.